Monitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation.

Lee, Jong-Mi; Ahn, Ari; Min, Eun Jeong; Lee, Sung-Eun; Kim, Myungshin; Kim, Yonggoo

Lee, Jong-Mi; Ahn, Ari; Min, Eun Jeong; Lee, Sung-Eun; Kim, Myungshin; Kim, Yonggoo.

Afiliação

Lee JM; Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Ahn A; Catholic Genetic Laboratory Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Min EJ; Catholic Genetic Laboratory Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Lee SE; Department of Laboratory Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Kim M; Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Kim Y; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. lee86@catholic.ac.kr.

Blood Cancer J ; 13(1): 97, 2023 06 26.

Article em En | MEDLINE | ID: mdl-37365186

Assuntos

Transplante de Células-Tronco Hematopoéticas; Mielofibrose Primária; Humanos; Mielofibrose Primária/genética; Mielofibrose Primária/terapia; Quimerismo; Mutação de Sentido Incorreto; Janus Quinase 2/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mielofibrose Primária Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google